{
    "2021-08-30": [
        [
            {
                "time": "",
                "original_text": "泰格医药(03347)股东曹晓春新增质押260万股及解除质押250万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "股东",
                        "曹晓春",
                        "新增质押",
                        "解除质押"
                    ],
                    "sentiment_score": -0.1,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：股东曹晓春累计质押股数为1040万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "股东",
                        "曹晓春",
                        "累计质押"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347)：上半年业绩恢复快速增长 回购彰显未来发展信心",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "上半年业绩",
                        "快速增长",
                        "回购",
                        "发展信心"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "麦格理：将泰格医药H股评级上调至跑赢大盘，目标价191.17港元。",
                "features": {
                    "keywords": [
                        "麦格理",
                        "泰格医药",
                        "H股",
                        "评级上调",
                        "跑赢大盘",
                        "目标价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}